These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2559609)

  • 1. Genetic engineering and properties of novel herpes simplex viruses for use as potential vaccines and as vectors of foreign genes.
    Meignier B; Roizman B
    Adv Exp Med Biol; 1989; 257():187-92. PubMed ID: 2559609
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus).
    Meignier B; Martin B; Whitley RJ; Roizman B
    J Infect Dis; 1990 Aug; 162(2):313-21. PubMed ID: 2165104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex viruses: is a vaccine tenable?
    Whitley RJ; Roizman B
    J Clin Invest; 2002 Jul; 110(2):145-51. PubMed ID: 12122103
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents.
    Meignier B; Longnecker R; Roizman B
    J Infect Dis; 1988 Sep; 158(3):602-14. PubMed ID: 2842408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for vaccines for herpes simplex viruses.
    Berman PW
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):226-30. PubMed ID: 2828443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary studies on infection by attenuated Salmonella in guinea pig and on expression on herpes simplex virus.
    Bowen JC; Alpar O; Phillpotts R; Roberts IS; Brown MR
    Res Microbiol; 1990; 141(7-8):873-7. PubMed ID: 1966255
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes simplex vaccines.
    Whitley RJ; Meignier B
    Biotechnology; 1992; 20():223-54. PubMed ID: 1318135
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes simplex virus vaccines as immunotherapeutic agents.
    Stanberry LR
    Trends Microbiol; 1995 Jun; 3(6):244-7. PubMed ID: 7648034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus recombinants as potential herpes simplex virus vaccines.
    Rooney JF; Wohlenberg CR; Notkins AL
    Adv Exp Med Biol; 1992; 327():183-9. PubMed ID: 1338264
    [No Abstract]   [Full Text] [Related]  

  • 11. [Herpes vaccines].
    Novitskiĭ VA; Pushkarskaia NL; Barinskiĭ IF
    Vopr Virusol; 1987; 32(3):261-77. PubMed ID: 2823480
    [No Abstract]   [Full Text] [Related]  

  • 12. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for vaccination against herpes simplex virus.
    Whitley RJ
    Pediatr Ann; 1993 Dec; 22(12):726, 729-32. PubMed ID: 8139874
    [No Abstract]   [Full Text] [Related]  

  • 14. Animal studies on the efficacy of an inactivated herpes simplex virus vaccine against recurrent herpes infection.
    Scriba M
    Infection; 1978; 6(3):137-9. PubMed ID: 210127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection.
    Manservigi R; Negrini M; Gualandri R; Milanesi G; Barbanti-Brodano G
    Adv Exp Med Biol; 1989; 257():263-71. PubMed ID: 2559611
    [No Abstract]   [Full Text] [Related]  

  • 16. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
    Fraser NW; Valyi-Nagy T
    Microb Pathog; 1993 Aug; 15(2):83-91. PubMed ID: 8255209
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
    Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
    J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and stability of herpes simplex virus antigens in Salmonella typhimurium.
    Bowen JC; Reddy RM; Alpar HO; Brown MR; Rouse BT
    Adv Exp Med Biol; 1995; 371B():1543-6. PubMed ID: 7502853
    [No Abstract]   [Full Text] [Related]  

  • 19. The owl monkey (Aotus trivirgatus) as an animal model for viral diseases and oncologic studies.
    Barahona H; Melendez LV; Hunt RD; Daniel MD
    Lab Anim Sci; 1976 Dec; 26(6 Pt 2):1104-12. PubMed ID: 190472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates.
    Parker JN; Pfister LA; Quenelle D; Gillespie GY; Markert JM; Kern ER; Whitley RJ
    Vaccine; 2006 Mar; 24(10):1644-52. PubMed ID: 16243413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.